Considering that obesity and metabolic abnormalities often coexist, our findings demonstrate that the strength of association of ferritin and transferrin with different metabolic obesity phenotypes varies, which emphasizes the importance of taking full account of the metabolic status of obese subjects when treating their iron dysfunction. Here, TF is linked to obesity disorder.